Driving forward our vision of developing the engineering biology ecosystem within Ontario and Canada, Ontario Genomics is enabling start-ups by providing investment and in-kind support through the Landing Pad Investment Program (LPIP).
The Landing Pad Investment Program aligns well with our strategic goals to advance genomics, applied research, and innovation to drive industry’s competitiveness, by providing access to high-risk investment, fostering connections between businesses, funders, investors and others, and advocating for policies that enable commercialization and implementation of genomics-based technologies. This enables a higher return on investments in genomics technology research, development and commercialization, filling a critical gap in Ontario’s life sciences ecosystem.
Ontario Genomics offers support to start-ups that attend an International Accelerator Program and wish to return to Ontario upon completion. Our official partner IndieBio (San Francisco & New York), backed by the global venture capital firm SOSV., offers $250,000 USD to companies accepted to their program. Successful applicants returning to Ontario from IndieBio or another approved international accelerator program may receive up to $100,000 CAD in investment from Ontario Genomics.
We are also working with Ontario Incubator Partners to provide access to laboratory space and mentorship. The mentorship includes regulatory pathway assistance, global outlook and connections, understanding of export markets, business model strategy, technical development, funding and foreign investment. Our partners are some of Ontario’s leading incubators and support organizations such as Velocity, Synapse, McMaster Innovation Park and Toronto Metropolitan University’s Science Discovery Zone (SDZ).